Important considerations for drugs, nutritional, and herbal supplements in pediatric solid organ transplant recipients

被引:2
|
作者
Pilch, Nicole A. [1 ]
Sell, Megan L. [2 ]
McGhee, William [3 ]
Venkataramanan, Raman [4 ]
机构
[1] Med Univ South Carolina, Transplant ICCE, Dept Pharm Practice & Outcomes Sci, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Transplant ICCE, Pediat Solid Organ Transplant & Surg, Charleston, SC 29425 USA
[3] UPMC Childrens Hosp Pittsburgh, Transplantat Ambulatory Care, Pittsburgh, PA USA
[4] UPMC, Thomas Starzl Transplantat Inst, Sch Pharm & Med, Pittsburgh, PA USA
关键词
cyclosporine; dietary supplement; herbal products; immunosuppression; pediatric; tacrolimus; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MYCOPHENOLATE-MOFETIL; RELEASE FORMULATION; GENERIC TACROLIMUS; DOUBLE-BLIND; BIOEQUIVALENCE; ANALGESICS; PROBIOTICS; CONVERSION; STABILITY;
D O I
10.1111/petr.13881
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Pediatric transplant recipients are on multiple prescription and non-prescription drugs. Many patients also use dietary, nutritional, and herbal supplements. This manuscript researched formulations of immunosuppressive drugs currently available and presents information on generic immunosuppressive drugs, commonly used non-prescription medications, dietary supplements, and herbal supplements. Immunosuppressive drugs are available in various formulations. Not all formulations are interchangeable. A number of FDA-approved generic formulations are available commercially in the United States. Generally generic formulations produce similar blood concentration vs time profiles compared to brand name products in adults and are considered to be bioequivalent. NSAID should be avoided in transplant patients due to potential drug interactions and increased risk associated with NSAID use; and appropriate doses of acetaminophen should be used for treatment of pain. Over-the-counter medications, such as guaifenesin and dextromethorphan, antihistamine medications, including diphenhydramine, loratadine, cetirizine, and fexofenadine, can be safely used in pediatric solid organ transplant population. Many safe and effective over-the-counter options exist for stool softening and as laxative. Diarrhea can lead to an increase in calcineurin inhibitor levels. Food can alter the absorption of immunosuppressive drugs. Several herbal products can alter immune status of the patients or alter the blood concentration of immunosuppressive drugs or may produce renal or hepatic toxicities and should be avoided in pediatric transplant recipients. It is important to educate pediatric transplant recipients and their families about not only immunosuppressive drug therapy but also about non-prescription drugs, dietary, and herbal supplement use.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Clostridium difficile Infection in Pediatric Solid Organ Transplant Recipients
    Pant, Chaitanya
    Deshpande, Abhishek
    Desai, Madhav
    Jani, Bhairvi S.
    Sferra, Thomas
    Abbaszadeh, Ali
    Oropeza-Vail, Melissa
    Gilroy, Richard
    Olyaee, Mojtaba
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S985 - S986
  • [22] Cytomegalovirus (CMV) Prevention in Pediatric Solid Organ Transplant Recipients
    Suresh, S.
    Lee, B.
    Robinson, J.
    Akinwumi, M.
    Preiksaitis, J.
    TRANSPLANTATION, 2014, 98 : 236 - 237
  • [23] Subclinical cardiovascular changes in pediatric solid organ transplant recipients
    Reusz, George
    Cseprekal, Orsolya
    Degi, Arianna
    Kis, Eva
    PEDIATRIC TRANSPLANTATION, 2016, 20 (04) : 482 - 484
  • [24] Characterization of sirolimus metabolites in pediatric solid organ transplant recipients
    Filler, Guido
    Bendrick-Peart, Jamie
    Strom, Tobin
    Zhang, Yan Ling
    Johnson, Gillian
    Christians, Uwe
    PEDIATRIC TRANSPLANTATION, 2009, 13 (01) : 44 - 53
  • [25] Invasive Fungal Disease in Pediatric Solid Organ Transplant Recipients
    Saxena, Shikha
    Gee, Jerica
    Klieger, Sarah
    Kajon, Adriana
    Petersen, Hans
    Zaoutis, Theoklis
    Fisher, Brian
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (03) : 219 - 225
  • [26] Post-Transplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients
    Wistinghausen, Birte
    Gross, Thomas G.
    Bollard, Catherine
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2013, 30 (06) : 520 - 531
  • [27] Herbal supplements: A potential for drug interactions in transplant recipients
    Barone, GW
    Gurley, BJ
    Ketel, BL
    Abul-Ezz, SR
    TRANSPLANTATION, 2001, 71 (02) : 239 - 241
  • [28] Pharmacologic Considerations for Solid Organ Transplant Recipients Who Become Pregnant
    Casale, Jillian P.
    Doligalski, Christina T.
    PHARMACOTHERAPY, 2016, 36 (09): : 971 - 982
  • [29] Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients
    Andrews, Louise M.
    Riva, Natalia
    de Winter, Brenda C.
    Hesselink, Dennis A.
    de Wildt, Saskia N.
    Cransberg, Karlien
    van Gelder, Teun
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (06) : 921 - 936
  • [30] Cytomegalovirus infection in pediatric solid organ transplant recipients and role of prophylaxis
    Nance, Gwen
    Serluco, Anastacia
    Deshpande, Shri
    Garro, Rouba
    George, Roshan
    Kelleman, Michael
    Yildrim, Inci
    Liverman, Rochelle
    PEDIATRIC TRANSPLANTATION, 2019, 23